GlaxoSmithKline Consumer Health has informed that it has submitted the revised scrutinizers report in relation to the business transacted through (i) postal ballot; (ii) e-voting process; and (iii) polling paper at the venue of the meeting of the equity shareholders of GlaxoSmithKline Consumer Healthcare Limited (Company) convened and held on Saturday, June 1, 2019 at 12:00 Noon at Punjab Public School Auditorium, The Punjab Public School (Senior Wing), Nabha - 147201, Punjab pursuant to an order dated April 12, 2019 in Company Application No. CA (CAA) No. 4/Chd/Pb/2019, passed by the Honble Chandigarh bench of the National Company Law Tribunal, for approving with or without modification(s), the proposed scheme of amalgamation among the Company and Hindustan Unilever Limited and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 (Scheme).
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Varun Beverages | 474.05 |
| Nestle | 1285.65 |
| Britannia Inds | 5733.75 |
| LT Foods | 422.10 |
| Hatsun Agro Product | 979.20 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: